Nymox Wins Big on Late-Stage Trial
Nymox Pharmaceutical shares jumped following the announcement of positive results from its late-stage prostate cancer trial.
All Work
Chris Lange
September Traffic Report: Southwest Versus United
Both Southwest Airlines and United Continental reported their September traffic numbers on Tuesday morning. Overall, the numbers were not earth-shattering.
KemPharm Rises on Key FDA Approval
KemPharm shares saw a solid gain on Tuesday following a key FDA approval on it treatment for attention deficit hyperactivity disorder.
Rent-A-Center Gets Burned on Preliminary Q3 Results
Rent-A-Center saw its shares take a dive early on Tuesday after the company gave a preliminary report on selected third-quarter financial information.
Merrimack Pharma Rises on Positive Late-Stage Results
Merrimack Pharmaceuticals shares saw a handy gain early Tuesday after the company announced positive results for its late stage metastatic pancreatic cancer study.
Illumina Stumbles Over Q3 Sales Update
When Illumina issued an update on its sales for the third quarter, the numbers came in below what analysts were looking for, and as a result investors sent the stock lower.
Mazor Robotics Rises on Pre-Launch Orders
Mazor Robotics Ltd. (NASDAQ: MZOR) is watching its shares rise handily on Monday after the company announced that it has received the first pre-launch orders for its guidance platform for spine surgeries. The Mazor X…
IntelliPharmaCeutics Soars on Tentative FDA Approval
IntelliPharmaCeutics International Inc. (NASDAQ: IPCI) is watching its shares jump on Monday after the company announced that it received a tentative approval from the U.S. Food and Drug Administration. Specifically, the tentative approval was…
What to Expect From Barracuda Networks Earnings
Barracuda Networks is scheduled to release its fiscal second-quarter financial results after the markets close on Tuesday.
Azure Power Updates Potential Pricing for IPO
Azure Power Global expects to price more than 3 million shares in the range of $21 to $23 per share for an initial public offering valued up to more than $90 million.
Monday’s 3 Major Biopharma Movers
On Monday morning, Merck, Mylan and Bristol-Myers Squibb made substantial runs, either up or down.
Dover Slides on Updated Guidance and Acquisition Investigation
Dover shares slid early on Monday after the company issued a business update for the third quarter and the rest of the year. Unfortunately, this update was not what investors were looking for.
How 2 Major Unicorns Are Cashing In on Their Incredible Gains
Twilio and fellow unicorn Acacia Communications are having secondary offerings to cash in on their massive runs over the summer.
Exelixis Continues Massive Run With Positive Cabosun Results
Shares of Exelixis saw a handy gain early Monday morning after the company reported positive results from its mid-stage trial for the treatment of renal cell carcinoma.
Top 5 Earnings for the Coming Week
24/7 Wall St. has put together a preview of Wells Fargo, Citigroup and some of the other major companies reporting their quarterly results this week.
What Analysts Are Saying About Micron After Earnings
Here are some of the key highlights from the Micron Technology earnings report, as well as what analysts are saying after the fact.
5 Companies That Destroyed Shareholders This Past Week
The late-summer doldrums are over and the markets are on the move again as we are now in the fourth quarter. But a few companies held the market back from pushing even higher.
CRISPR Therapeutics Prepares for IPO
CRISPR Therapeutics expects to price more than 4 million shares in the range of $15 to $17 apiece for an initial public offering valued up to nearly $92 million.
Forterra Sets Expected Price Range for IPO
Forterra expects to price more than 18 million shares in the range of $19 to $21 apiece for an initial public offering valued up to more than $444 million.
Breaking Down the Camping World IPO
Camping World Holdings entered the market on a positive note, with shares going out at the mid-point in their expected price range of $21 to $23.